Plus   Neg

Corcept Therapeutics Inc. (CORT) Pulled Back On News Of Generic Competition

Corcept Therapeutics Inc. (CORT) gapped open sharply lower Monday and dropped further in early trade, before settling into a range. Shares finished with a loss of 6.20 at $17.26 on strong volume. The stock dropped to over a 1-month low.

Corcept Therapeutics was under pressure after Teva Pharmaceutical Industries (TEVA) submitted a new drug application for a generic version of the company's Korlym drug.

For comments and feedback contact: editorial@rttnews.com

Business News

Get Access to Premium Stock Alerts with RTT Intelligent Investor.
Follow RTT